Literature DB >> 24520007

Clinical characteristics and risk factors of diabetic foot ulcer with multidrug-resistant organism infection.

Xiaoyan Ji1, Peng Jin, Yuejie Chu, Shuhong Feng, Penghua Wang.   

Abstract

The objective was to determine multidrug-resistant organisms' (MDROs) profile in diabetic foot ulcers (DFU), antibiotic resistance of MDROs, and to find the potential risk factors for infection with MDROs. In 157 patients with DFU admitted to Tianjin Metabolic Disease Hospital, China, from January 2011 to January 2012, microbiological specimens were taken on admission. The patients were divided into 2 groups according to the infection of MDROs. Potential risk factors for MDRO-positive specimens were examined using univariate and multivariate analyses. Seventy-eight MDRO strains were isolated from patients in the MDRO+ group, among which the top 3 were Staphylococcus aureus (16.7%), Enterobacter spp (16.7%), and Pseudomonas aeruginosa (15.4%). Most of the MDROs were resistant to at least 8 kinds of commonly used antibiotics. Gram-negative MDROs showed 23% to 50% resistance to third-generation cephalosporins. The resistant rates of Gram-positive MDROs to fluoroquinolone were more than 70%; penicillin and semisynthetic penicillin were 57% to 100% resistant. Previous hospitalization (odds ratio [OR] = 3.000; 95% confidence interval [CI] = 1.100-8.182; P = .032), previous duration of antibiotic therapy (OR = 1.078; 95% CI = 1.001-1.160; P = .046), ulcer type (OR = 7.185; 95% CI = 2.115-24.408; P = .002), ulcer size (OR = 1.403; 95% CI = 1.042-1.888; P = .026), and osteomyelitis (OR = 3.390; 95% CI = 1.178-9.756; P = .024) were associated with MDRO infection in patients with DFU.

Entities:  

Keywords:  diabetic foot ulcer; infection; multidrug-resistant organisms; risk factor

Mesh:

Substances:

Year:  2014        PMID: 24520007     DOI: 10.1177/1534734614521236

Source DB:  PubMed          Journal:  Int J Low Extrem Wounds        ISSN: 1534-7346            Impact factor:   2.057


  7 in total

1.  Distribution of Microbes and Drug Susceptibility in Patients with Diabetic Foot Infections in Southwest China.

Authors:  Mingxia Wu; Hang Pan; Weiling Leng; Xiaotian Lei; Liu Chen; Ziwen Liang
Journal:  J Diabetes Res       Date:  2018-08-05       Impact factor: 4.011

2.  Development of predictive nomograms for clinical use to quantify the risk of isolating resistance prone organisms in patients with infected foot ulcers.

Authors:  A Farkas; F Lin; K Bui; F Liu; G L An; A Pakholskiy; C F Stavropoulos; J C Lantis; A Yassin
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

3.  Multidrug-resistant bacteria in diabetic foot infections: Experience from a portuguese tertiary centre.

Authors:  Tomás Pessoa E Costa; Bruno Duarte; Ana Luísa João; Miguel Coelho; Ana Formiga; Margarida Pinto; José Neves
Journal:  Int Wound J       Date:  2020-08-21       Impact factor: 3.315

4.  Multicentre study of the burden of multidrug-resistant bacteria in the aetiology of infected diabetic foot ulcers.

Authors:  Adeyemi T Adeyemo; Babatope Kolawole; Vincent O Rotimi; Aaron O Aboderin
Journal:  Afr J Lab Med       Date:  2021-03-23

5.  Risk Factors for Multidrug-Resistant Organisms Infection in Diabetic Foot Ulcer.

Authors:  Xinbang Liu; Qiuyue Ren; Yangkui Zhai; Yihan Kong; Dong Chen; Bai Chang
Journal:  Infect Drug Resist       Date:  2022-04-07       Impact factor: 4.003

Review 6.  An Overview of Diabetic Foot Ulcers and Associated Problems with Special Emphasis on Treatments with Antimicrobials.

Authors:  Mirza Shahed Baig; Ahmadi Banu; Mehrukh Zehravi; Ritesh Rana; Sushil S Burle; Sharuk L Khan; Fahadul Islam; Falak A Siddiqui; Ehab El Sayed Massoud; Md Habibur Rahman; Simona Cavalu
Journal:  Life (Basel)       Date:  2022-07-14

Review 7.  The Influence of Multidrug-Resistant Bacteria on Clinical Outcomes of Diabetic Foot Ulcers: A Systematic Review.

Authors:  Gianmarco Matta-Gutiérrez; Esther García-Morales; Yolanda García-Álvarez; Francisco Javier Álvaro-Afonso; Raúl Juan Molines-Barroso; José Luis Lázaro-Martínez
Journal:  J Clin Med       Date:  2021-05-01       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.